Switching on the evolutionary potential of pancreatic cancer: the tumor suppressor functions of PBRM1
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci193205 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Luigi Perelli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genitourinary Medical Oncology. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Transcription Factors, Nuclear Proteins. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genitourinary Medical Oncology.
- TRACTION platform, and.
- Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Perelli, L., & Genovese, G. (2025). Switching on the evolutionary potential of pancreatic cancer: the tumor suppressor functions of PBRM1. Journal of Clinical Investigation. https://doi.org/10.1172/jci193205
Vancouver
Perelli L, Genovese G. Switching on the evolutionary potential of pancreatic cancer: the tumor suppressor functions of PBRM1. Journal of Clinical Investigation. 2025. doi:10.1172/jci193205
BibTeX
@article{Perelli2025,
author = {Perelli, Luigi and Genovese, Giannicola},
title = {Switching on the evolutionary potential of pancreatic cancer: the tumor suppressor functions of PBRM1},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci193205}
}
EUVIMED